AIIC
APLS

AJU IB Investment Company’s Apellis Pharmaceuticals APLS Stock Holding History

AJU IB Investment Company’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-624,962
Closed -$20.6M – 7
2021
Q3 		$20.6M Sell
624,962
-440,000
-41% -$24.7M 13.29% 4
2021
Q2 		$67.3M Sell
1,064,962
-50,000
-4% -$2.58M 38.81% 1
2021
Q1 		$47.8M Hold
1,114,962
– – 18.05% 3
2020
Q4 		$63.8M Buy
+1,114,962
New +$47.2M 24.13% 2

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

AJU IB Investment Company's APLS Position: Q4 2021 in Review

AJU IB Investment Company sold out of Apellis Pharmaceuticals (APLS) in Q4 2021, closing a stake of 624,962 shares — an estimated $20.6M sold.

AJU IB Investment Company first reported a position in APLS in Q4 2020 and held it in 4 quarters. The position peaked at $67.3M in Q2 2021. 186 funds tracked by Wall St. Rank hold APLS as of Q4 2021.

  • AJU IB Investment Company reported no remaining Apellis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • AJU IB Investment Company sold 624,962 Apellis Pharmaceuticals shares in Q4 2021, an estimated $20.6M.
  • AJU IB Investment Company first reported a position in Apellis Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • AJU IB Investment Company's Apellis Pharmaceuticals position peaked at $67.3M in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2021.

Based on AJU IB Investment Company's 13F filing for Q4 2021, filed 9 Feb 2022.